In addition, the control groups, including free SL9 alone and the mixture of free SL9 and CpG, did not exhibit significant efficacy in activating T cells, release of IFN-γ or inhibition of tumor growth, which was attributed to the inability of free SL9 and free CpG to drain to lymph nodes. The gene discussed is IFNG; the disease is neoplasm.